<?xml version="1.0" encoding="UTF-8"?>
<p>Cryptotanshinone (
 <xref ref-type="fig" rid="F5">Figure 5</xref>), as the main active ingredient of 
 <italic>S. miltiorrhiza</italic>, possesses many pharmaceutical functions including anti-AChE (
 <xref rid="B165" ref-type="bibr">165</xref>), anti-neurotoxicity (
 <xref rid="B166" ref-type="bibr">166</xref>), anti-inflammatory (
 <xref rid="B167" ref-type="bibr">167</xref>), anti-oxidative (
 <xref rid="B168" ref-type="bibr">168</xref>), and anti-apoptotic activities (
 <xref rid="B169" ref-type="bibr">169</xref>). Cryptotanshinone is reported to reduce Aβ deposition and improve spatial learning impairment (
 <xref rid="B170" ref-type="bibr">170</xref>). By affecting the gamma-secretase pathway, it prevents Aβ plaque formation and inhibits glutamate-induced neuronal toxicity (
 <xref rid="B166" ref-type="bibr">166</xref>). It is reported that cryptotanshinone ameliorates cognitive disturbance and significantly affect amnesia (
 <xref rid="B165" ref-type="bibr">165</xref>). 
</p>
